Exploring the synergistic effects of cabozantinib and a programmed cell death protein 1 inhibitor in metastatic renal cell carcinoma with machine learning

  1. Durán, I.
  2. Castellano, D.
  3. Puente, J.
  4. Martín-Couce, L.
  5. Bello, E.
  6. Anido, U.
  7. Mas, J.M.
  8. Costa, L.

ISSN: 1949-2553

Year of publication: 2022

Volume: 13

Pages: 237-256

Type: Article

DOI: 10.18632/ONCOTARGET.28183 GOOGLE SCHOLAR lock_openOpen access editor